期刊文献+

阿伐他汀对成年大鼠心肌成纤维细胞分泌内皮素-1及一氧化氮合酶/一氧化氮系统活性的影响 被引量:12

Effect of atorvastatin on the ET-1 and NOS-NO system activity in adult rat cardiac fibroblasts
下载PDF
导出
摘要 目的 :探讨阿伐他汀 (Atorvastatin)对大鼠心肌成纤维细胞 (CFs)分泌内皮素 1(ET 1)含量及一氧化氮合酶 /一氧化氮 (NOS NO)系统活性的影响。 方法 :采用胰蛋白酶和胶原酶混合消化法 ,差速贴壁获取CFs。应用放免法、硝酸还原酶法和分光光度法分别测定不同干预条件下CFs培养液中ET 1水平及NOS NO活性。 结果 :①阿伐他汀呈浓度依赖性抑制CFs分泌ET 1,10 -6、10 -5和 10 -4mol/L阿伐他汀组与对照组相比差异非常显著 (均P <0 .0 1) ;10 -5和 10 -4mol/L阿伐他汀组分别与 10 -7和 10 -6mol/L阿伐他汀组相比差异非常显著 (均P <0 .0 1)。②阿伐他汀可升高CFsNO含量 ,10 -5和 10 -4mol/L阿伐他汀组与对照组相比差异显著 (P <0 .0 5 )和非常显著 (P <0 .0 1) ;10 -4mol/L阿伐他汀组与 10 -7mol/L阿伐他汀组相比差异显著 (P <0 .0 5 )。③阿伐他汀可增强CFsNOS活性 ,10 -5和 10 -4mol/L组阿伐他汀与对照组相比差异显著 (P <0 .0 5 )或非常显著 (P <0 .0 1) ;10 -4mol/L与 10 -7mol/L阿伐他汀组相比差异显著 (P <0 .0 5 )。 结论 :阿伐他汀能抑制CFs分泌ET 1,提高CFsNOS NO系统活性 ,拮抗血管紧张素Ⅱ (AngⅡ )的部分生物活性 ,发挥其逆转心室重塑。 Objectives: To investigate the effects of Atorvastatin on the secretion of ET 1 and NOS NO activity from adult rat cardiac fibroblasts (CFs). Methods: Isolated and cultured CFs of adult Sprague Dawley (SD) rats were used as experiment model. The change of Endothelin 1 (ET 1) was measured by radioimmunoassay. Nitric oxide (NO) content and nitric oxide synthase (NOS) activity were measured by spectrophotometry. Results: ① The secretion of ET 1 from CFs decreased graduately with the elevation of Atorvastatin concentrations.The content of ET 1 in 10 -7 mol/L, 10 -6 mol/L, 10 -5 mol/L and 10 -4 mol/L Atorvastatin groups were significantly lower than that of control group (all P < 0.01) . ② The content of NO in 10 -5 mol/L and 10 -4 mol/L Atorvastatin groups were significantly higher than that of control group(all P <0.05). ③ There was very significant increase of NOS activity in 10 -5 mol/L and 10 -4 mol/L Atorvastatin groups, compared with control group(all P <0.05). Conclusions:Atorvastatin have inhibitory effects on the secretion of ET 1 and increase the NOS NO activity in cultured adult rat CFs.
出处 《医学研究生学报》 CAS 2003年第10期733-735,739,共4页 Journal of Medical Postgraduates
基金 国家重点基础研究发展规划 ( 973 )课题基金资助项目 (批准号 :G .2 0 0 0 5 70 0 4) 陕西省科学技术研究发展计划基金资助项目〔批准号 :2 0 0 2K10 G1( 2 3 )〕
关键词 阿伐他汀 心肌成纤维细胞 内皮素-1 一氧化氮 一氧化氮合酶 心室重塑 Atorvastatin Cardiac fibroblasts Endothelin 1 Nitric oxide Nitric oxide synthase Heart remodeling
  • 相关文献

参考文献15

  • 1Miyauchi T, Masaki T. Pathophysiology of endothelin in the cardiovascular system[J]. Annu Rev Physiol, 1999, 61:391-415.
  • 2詹昌德.一氧化氮在防止心肌肥厚反应中的作用及其机制[J].生理科学进展,2000,31(4):322-324. 被引量:43
  • 3Lefer AM, Scalia R, Lefer DJ. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowerng: new concepts for cardiovascular disease[J]. Cardiovasc Res, 2001, 49(2): 281-287.
  • 4田建伟,赵连友,王士雯,张海涛,郑强荪,杨学东,徐琳,范延红.阿伐他汀对幼年大鼠心肌成纤维细胞增殖和胶原合成的影响及其意义[J].中华医学杂志,2003,83(2):118-122. 被引量:26
  • 5Diez J, Lopez B, Gonzalez A et al. Clinical aspects of hypertensive myocardial fibrosis[J]. Curr Opin Cardiol,2001,16(6):328-335.
  • 6Booz GW, Baker KM. Molecular signaling mechanisms controlling growth and function of cardiac fibroblasts[J]. Cardiovas Res, 1995, 30(4): 537-543.
  • 7The LIPID study group. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up[J]. Lancet, 2002,359(9315): 1379-1387.
  • 8徐琳,赵连友,等.他汀类药物与细胞增殖性心血管疾病的关系的研究现状[J].心脏杂志,2002,14(2):162-164. 被引量:5
  • 9Bauer SJ, Galuppo P, Fraccarollo D et al. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction[J]. Circulation, 2001, 104(9): 982-985.
  • 10Hayashidani S, Tsutsui H, Shiomi T et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction[J]. Circulation,2002, 105(7):868-873.

二级参考文献27

  • 1[1]Negre-aminou P,Vliet AK,Erck M,et al.Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types[J].Biochem Biophys Acta,1997,1345: 259-268.
  • 2[2]Jiang J,Roman RJ.Lovastatin prevents development of hypertension in spontaneously hypertensive rats [J].Hypertension,1997,30:968-974.
  • 3[3]Laufs U,Marra D,Node K,et al.3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing Rho GTPase-induced down-regulation of P27kip1 [J].J Bio Chem,1999,274:21926-21931.
  • 4[4]Guijarro C,Blanco-Colio LM,Ortego M,et al.3-hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture [J].Circ Res,1998,83:490-500.
  • 5[5]Kano H,Hayashi T,Sumi D,et al.A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO Synthase mRNA [J].Biochem Biophys Res Commu,1999,259:414-419.
  • 6[6]Bellosta S,Via D,Canavesi M,et al.HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages[J].Arterioscle Thromb Vasc Biol,1998,18:1671-1678.
  • 7[7]Vrtovsnik F,Couettes,Prie D,et al.Lovastatin inhibition of renal epithelial tubular cell proliferation involves a P21ras activated AP-1-dependent pathway[J].Kidney Int,1997,52:1016-1027.
  • 8[8]Narisawa J,Morotomi M,Fukaura Y,et al.Chemoprevention by HMG-CoA reductase inhibitor of N-methyl-N-nitrosoureg induced colon carcinogenesis in F344 Rats[J].Jpn J Cancer Res,1996,87:798-804.
  • 9[9]Bellosta S,Bernini F,Ferri N,et al.Direct vascular effects of HMG-CoA reductase inhibitor[J].Atherosclerosis,1998,137:s101-s109.
  • 10[10]Corsini A,Pazzucconi F,Arnaboldi L,et al.Direct of Effects of statins on the Vascular Wall [J].J Cardiovasc Pharmacol,1998,31:773-778.

共引文献71

同被引文献157

引证文献12

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部